Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000580439 | SCV000682008 | benign | Hereditary cancer-predisposing syndrome | 2015-04-22 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000625500 | SCV000793843 | benign | Ataxia-telangiectasia syndrome | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679101 | SCV000805507 | benign | not specified | 2017-02-17 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001539978 | SCV001473264 | benign | not provided | 2024-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625500 | SCV001732529 | benign | Ataxia-telangiectasia syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001539978 | SCV001757807 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798902 | SCV002043610 | benign | Breast and/or ovarian cancer | 2021-05-26 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225673 | SCV002504969 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000679101 | SCV002760502 | benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316751 | SCV004016575 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003316751 | SCV005083854 | benign | Familial cancer of breast | 2024-04-17 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Breakthrough Genomics, |
RCV001539978 | SCV005230990 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000625500 | SCV000745802 | benign | Ataxia-telangiectasia syndrome | 2017-08-22 | no assertion criteria provided | clinical testing | |
Clinical Genetics Laboratory, |
RCV000679101 | SCV001905813 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000679101 | SCV001918352 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679101 | SCV001953978 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000679101 | SCV002036320 | benign | not specified | no assertion criteria provided | clinical testing |